General Motors Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

General Motors Investment Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-47,376	Closed	-$420K	–	810
2015 Q1	$420K	Buy	47,376 +9,526	+25%	+$75.9K	0.04%	565
2014 Q4	$332K	Hold	37,850	–	–	0.03%	650
2014 Q3	$261K	Sell	37,850 -16,014	-30%	-$96K	0.02%	715
2014 Q2	$283K	Buy	53,864 +15,196	+39%	+$73.9K	0.02%	712
2014 Q1	$176K	Buy	38,668 +7,544	+24%	+$36.4K	0.02%	847
2013 Q4	$157K	Buy	31,124 +7,872	+34%	+$37.9K	0.01%	885
2013 Q3	$118K	Hold	23,252	–	–	0.01%	891
2013 Q2	$115K	Buy	+23,252	New	+$111K	0.01%	870

Other funds holding SCLN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

General Motors Investment Management's SCLN Position: Q2 2015 in Review

General Motors Investment Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2015, closing a stake of 47,376 shares — an estimated $420K sold.

General Motors Investment Management first reported a position in SCLN in Q2 2013 and held it in 8 quarters. The position peaked at $420K in Q1 2015. 146 funds tracked by Wall St. Rank hold SCLN as of Q2 2015.

General Motors Investment Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
General Motors Investment Management sold 47,376 Sciclone Pharmaceuticals Inc shares in Q2 2015, an estimated $420K.
General Motors Investment Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 8 quarters.
General Motors Investment Management's Sciclone Pharmaceuticals Inc position peaked at $420K in Q1 2015.
146 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.